U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Bumetanide Injection
Status: Currently in Shortage
»Date first posted: 12/13/2017
»Therapeutic Categories: Cardiovascular

Expand all

Fresenius Kabi USA, LLC (Reverified 04/01/2025)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Bumetanide, Injection, .25 mg/1 mL (NDC 65219-570-04) Available Check wholesalers for inventory
Bumetanide, Injection, .25 mg/1 mL (NDC 65219-572-10) Available Check wholesalers for inventory

Hikma Pharmaceuticals USA, Inc. (Reverified 02/14/2025)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Bumetanide, Injection, .25 mg/1 mL (NDC 0641-6008-10) Available
Bumetanide, Injection, .25 mg/1 mL (NDC 0641-6007-10) Available

MSN Laboratories Private Limited (Reverified 02/17/2025)

Company Contact Information:
Distributed by: Novadoz Pharmaceuticals LLC; Telephone: (855) 668-2369; customerservice@novadozpharma.com

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Bumetanide, Injection, 0.25 mg/mL, 4mL (NDC 72205-101-01) Limited Availability Supply shortage Discontinuation of the manufacture of the drug
Bumetanide, Injection, .25 mg/1 mL (NDC 72205-101-07) Limited Availability Supply shortage Discontinuation of the manufacture of the drug
Bumetanide, Injection, 0.25 mg/mL, 10 mL (NDC 72205-102-01) Limited Availability Supply shortage Discontinuation of the manufacture of the drug
Bumetanide, Injection, .25 mg/1 mL (NDC 72205-102-07) Limited Availability Supply shortage Discontinuation of the manufacture of the drug

Sagent Pharmaceuticals (Revised 02/20/2025)

Company Contact Information:
866-625-1618

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Bumetanide, Injection, .25 mg/1 mL (NDC 70860-405-04) Unavailable Use Sagent NDC 25021-321-04 Other
Bumetanide, Injection, .25 mg/1 mL (NDC 70860-406-10) Unavailable Use Sagent NDC 25021-321-10 Other
Back to Top